In Vitro Susceptibility Testing of a Novel Benzimidazole, SPR719, against Nontuberculous Mycobacteria

Nontuberculous mycobacterium (NTM) infections are increasing globally. The Mycobacterium avium complex (MAC) and Mycobacterium abscessus are the most frequently encountered NTM among clinical laboratories, and treatment options are extremely limited. In this study, the in vitro potency of a novel be...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrob Agents Chemother
Main Authors: Brown-Elliott, Barbara A., Rubio, Aileen, Wallace, Richard J.
Format: Artigo
Language:Inglês
Published: American Society for Microbiology 2018
Subjects:
Susceptibility
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201134/
https://ncbi.nlm.nih.gov/pubmed/30126964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01503-18
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items